Nooceptin Review: Ingredients, Results, Safety & Value

Nooceptin is a caffeine-free nootropic supplement whose 3-capsule daily serving lists seven plant, mushroom and nutrient ingredients totalling 1,400 mg. The seven are lion’s mane, citicoline, L-theanine, Panax ginseng, Rhodiola rosea, Bacopa monnieri and Ginkgo biloba. No published trial of the finished formula was found in PubMed or ClinicalTrials.gov searches run in November 2026, so the evidence behind it is ingredient-level only.

L-theanine and Panax ginseng are at or above single doses that changed test scores in healthy adults. Bacopa and lion’s mane sit at half or less of their human trial doses, and ginkgo is close to a dose that improved nothing in a 6-week memory trial. The Effectiveness table gives every share for both products.

Nooceptin costs $67.00 for a 30-day bottle on nooceptin.com, or $2.23 per day. It fits adults who want ginseng and ginkgo in a stimulant-free capsule and accept ingredient-level evidence. Buyers who want a formula tested as a whole, or a 60-day first-order refund window, get both from Mind Lab Pro, the recommended alternative. Its three finished-formula trials are small and pseudo-randomised, and several of its own ingredient doses fall short (see the tables).

Our Nooceptin Verdict

Nooceptin earns a cautious verdict: the label discloses every amount and four of its five plant and mushroom extracts carry a stated standardisation (an adjusted share of a marker compound), but the evidence is ingredient-level only.

Mind Lab Pro is the recommended alternative: its finished formula has three small, pseudo-randomised placebo-controlled trials of 30 to 60 days (two with between-group differences on cognitive tests, one with none on reaction time or accuracy), and a 2-capsule serving lists 11 ingredients and no caffeine.

Pros of Nooceptin

• No caffeine or other stimulant is listed, and every ingredient amount is disclosed.
• L-theanine (200 mg) is about twice, and Panax ginseng (200 mg) equals, a single dose that improved a test score in healthy adults.
• Rhodiola (150 mg) and bacosides (60 mg) per serving exceed Mind Lab Pro’s (50 mg rhodiola, 36 mg bacosides).
• The price per day on the seller’s own website is below Mind Lab Pro’s for one bottle and for the cheapest order (see Price & Value for Money).

Cons of Nooceptin

• The evidence is ingredient-level; the Effectiveness table shows which label doses fall short of trial doses, and the seller’s “Savings” figures do not recompute (see Price & Value for Money).
• The seller’s capsule instructions conflict (see Nooceptin Dosage Instructions).
• Returns are accepted within 30 days only for unused items in the original packaging, and the policy excludes sale items.

About Nooceptin

Nooceptin is a stimulant-free capsule supplement, sold in bottles of 30 servings of 3 capsules (90 capsules). The seller’s terms of service name SAP Nutrition Ltd as the contact for the product.

The seller markets Nooceptin with phrases such as “7 Clinically Proven Ingredients”, “no side effects” and “Limitless Brainpower”; these are marketing, not trial results.

Nooceptin is a real, purchasable product, and nothing found points to a scam: the seller publishes its prices, names SAP Nutrition Ltd in its terms of service, lists every ingredient amount and offers a 30-day return window for unused items. Against it, the seller’s “Savings” figures do not recompute, its pages give conflicting capsule instructions and its pages state no third-party laboratory testing.

Nooceptin Ingredients & Supplement Facts

Nooceptin’s supplement-facts label lists seven active ingredients totalling 1,400 mg per 3-capsule serving:

• Lion’s mane extract (Hericium erinaceus, fruiting body, standardised to 30% polysaccharides): 400 mg
• Citicoline (cytidine 5’-diphosphocholine, sodium): 200 mg
• L-theanine: 200 mg
• Panax ginseng extract (root, no ginsenoside content stated): 200 mg
• Rhodiola rosea extract (root, standardised to 3% rosavins and 1% salidroside): 150 mg
• Bacopa monnieri extract (whole plant, standardised to 40% bacosides): 150 mg
• Ginkgo biloba extract (leaf, standardised to 24% flavone glycosides and 6% terpene lactones): 100 mg

At those standardisations, one serving supplies 120 mg of lion’s mane polysaccharides, 60 mg of bacosides, 4.5 mg of rosavins, 1.5 mg of salidroside, 24 mg of ginkgo flavone glycosides and 6 mg of terpene lactones.

Lion’s Mane Mushroom: 400 mg

Lion’s mane (Hericium erinaceus) is an edible mushroom studied for nerve growth factor (NGF) activity; the lion’s mane mushroom profile covers the wider evidence. Nooceptin uses 400 mg of a fruiting-body extract standardised to 30% polysaccharides and states no erinacine or hericenone content.

In cultured nerve cells, an aqueous lion’s mane extract combined with 10 ng/mL of NGF raised neurite outgrowth (growth of the branches that carry nerve signals) by 60.6% but failed to protect the cells from oxidative stress. ⁽¹⁾ Higher NGF signalling would, if it occurred in people, fit the memory goal that Lion’s Mane extract products target; this is inferred from cell data, not measured in people.

A human trial of lion’s mane gave 3 capsules of 350 mg erinacine A-enriched mycelia (the root-like body of the fungus) per day (1,050 mg) for 49 weeks to 49 adults with mild Alzheimer’s disease (41 completed); Mini-Mental State Examination (MMSE, a 30-point screening test of memory and orientation) scores in the lion’s mane group rose from 21.75 to 23.2, while comparisons between the lion’s mane and placebo groups were not significant. ⁽²⁾

Nooceptin’s 400 mg is under half of that 1,050 mg daily dose. The trial used erinacine A-enriched mycelia in people with Alzheimer’s disease, so its result does not transfer directly to either product: Nooceptin’s fruiting-body extract states no erinacine, and Mind Lab Pro’s 500 mg mycelium-and-fruit blend states none either.

Citicoline: 200 mg

Citicoline (CDP-choline) is a compound the body also makes, and it supplies choline and cytidine for cell-membrane phospholipids; the citicoline profile covers it in detail. Nooceptin lists 200 mg as citicoline sodium; one nooceptin.com product page lists 250 mg, and the supplement-facts label governs.

In 16 healthy adults with a mean age of 47 who took 500 mg (one capsule a day) or 2,000 mg (four capsules a day in a single dose) of Cognizin citicoline supplementation for 6 weeks, the brain energy compounds phosphocreatine and beta-nucleoside triphosphates (largely ATP) rose 7% and 14% respectively in the anterior cingulate cortex (a frontal brain region), and the changes tended to be larger at the lower dose. ⁽³⁾

In 75 healthy adolescent males, 28 days of 250 mg or 500 mg of Cognizin citicoline (51 participants; one capsule a day) improved attention (p = 0.02) and psychomotor speed (p = 0.03) compared with placebo (24 participants); a p value below 0.05 is the usual cut-off for a difference unlikely to be chance. ⁽⁴⁾

Nooceptin’s 200 mg is 80% of the 250 mg low arm of the attention trial and 40% of the 500 mg lower dose in the scan study. The attention trial enrolled adolescents and pooled both dose arms, so the result at 250 mg alone is not established; the same limit applies to Mind Lab Pro’s 250 mg.

L-Theanine: 200 mg

L-Theanine is an amino acid found in tea leaves and is taken for calm attention without sedation; the L-theanine profile covers its wider evidence. Nooceptin lists 200 mg.

In a randomised, placebo-controlled trial of Japanese adults aged 50 to 69 (26 analysed on theanine, 24 on placebo), a single 100.6 mg dose of L-theanine lowered reaction time on part 1 of the Stroop test (a computer reaction-time task using colour words) compared with placebo, while 12 weeks of one 100.6 mg capsule a day had no effect on attention. ⁽⁵⁾

Nooceptin’s 200 mg is 1.99 times that 100.6 mg dose.

L-Theanine is reported to raise alpha-wave brain activity and to modulate glutamate and GABA signalling; this is inferred from its mechanism and would fit the faster reaction time after one dose.

Panax Ginseng: 200 mg

Panax ginseng, also called Korean ginseng, is a root extract whose active constituents are ginsenosides; the Panax ginseng profile covers the herb. Nooceptin lists 200 mg of root extract and states no ginsenoside content.

In a crossover trial (each of the 30 healthy young adults took every treatment on separate days), a single 200 mg dose of G115 (a branded, standardised Panax ginseng extract) improved Serial Sevens subtraction (counting backwards in sevens) and lowered self-rated mental fatigue across repeated testing that began 60 minutes after the dose. ⁽⁶⁾

The ginseng study featured on the Nooceptin website gave Korean red ginseng, a steamed and dried Panax ginseng root preparation, at 1,000 mg per day for 8 weeks to 26 healthy adults, with 25 on placebo; composite scores for executive function, attention and memory improved more than with placebo (p = 0.03 in a test of whether the groups changed differently over time). ⁽⁷⁾

Nooceptin’s 200 mg matches the single G115 dose, but the 8-week study used 1,000 mg a day, 5 times as much, as two 500 mg capsules of an unspecified extract or powder; Nooceptin states no ginsenoside level, so milligrams are not strictly comparable.

Ginsenosides are reported to act on neurotransmitter and glucose-handling pathways (inferred from the mechanism).

Rhodiola Rosea: 150 mg

Rhodiola Rosea is a herb from cold, mountainous regions, sold for stress and fatigue; the Rhodiola rosea profile covers it in full. Nooceptin lists 150 mg of root extract standardised to 3% rosavins and 1% salidroside.

In a 20-day double-blind pilot during an examination period, students took two 50 mg tablets a day (100 mg per day) of the Rhodiola extract SHR-5 or placebo; the Rhodiola group improved on a neuro-motor maze test and on self-rated mental fatigue (p < 0.01) and on general well-being (p < 0.05), and the authors judged the dose probably suboptimal. ⁽⁸⁾

In an open-label pilot without a placebo group, 10 adults with generalized anxiety disorder took 340 mg of Rhodiola rosea extract per day for 10 weeks; their Hamilton Anxiety Rating Scale (a clinician-scored anxiety checklist) scores fell (p = 0.01). ⁽⁹⁾

Nooceptin’s 150 mg is under half of the 340 mg dose in the anxiety pilot, which measured anxiety, not cognition, and 1.5 times the 100 mg per day of the exam-period study.

Rhodiola is described as an adaptogen (a herb said to help the body cope with stress), with reported effects on serotonin and dopamine signalling (inferred from its mechanism) that would fit the fatigue and anxiety scores.

Bacopa Monnieri: 150 mg

Bacopa monnieri is a traditional Ayurvedic herb whose active compounds are called bacosides; the Bacopa monnieri profile covers it in full. Nooceptin lists 150 mg of whole-plant extract standardised to 40% bacosides, which is 60 mg of bacosides.

In a 12-week randomised trial in 98 healthy adults over 55 (81 completed), 300 mg per day of a Bacopa Monnieri extract (BacoMind) improved delayed word recall compared with placebo (p = 0.001). ⁽¹⁰⁾

In rats, 40 mg/kg and 80 mg/kg of bacopa extract fed daily for 4 and 6 weeks increased dendritic branching of neurons in the basolateral amygdala, a region involved in learning and memory. ⁽¹¹⁾ By the body-surface-area rule (animal dose x Km rat 6 / Km human 37, where Km is a scaling constant), 40 mg/kg converts to 6.5 mg/kg, about 454 mg for a 70 kg adult, and 80 mg/kg to 13.0 mg/kg, about 908 mg: an estimate from animal data, not a tested dose, and whether it carries to people is inferred.

Nooceptin’s 150 mg is half of the 300 mg human trial dose. Mind Lab Pro lists the same 150 mg at 24% bacosides (36 mg); the trial’s BacoMind (a branded extract) was standardised to 40% to 50% total bacosides, so 300 mg holds 120 to 150 mg, of which Nooceptin’s 60 mg is 40% to 50% and Mind Lab Pro’s 36 mg is 24% to 30%.

Ginkgo Biloba: 100 mg

Ginkgo biloba is a leaf extract of the ginkgo tree, marketed for memory and circulation; the Ginkgo biloba profile covers its wider evidence. Nooceptin lists 100 mg standardised to 24% flavone glycosides and 6% terpene lactones.

In a 6-week randomised trial of 230 adults over 60 without cognitive impairment, ginkgo at 40 mg three times a day (120 mg per day, 115 per group) produced no significant difference from placebo on any memory, attention, concentration or language measure. ⁽¹²⁾

Nooceptin’s 100 mg of Ginkgo Biloba extract is close to that 120 mg daily dose, so the trial gives no support for a memory effect from Nooceptin’s ginkgo in healthy older adults.

Ginkgo is reported to have antioxidant and blood-flow actions (inferred from the mechanism), but the 6-week trial found no memory benefit.

Effectiveness & Results

Because the evidence is ingredient-level, the table compares each label amount with the human study dose described above; each share is the label amount divided by the study’s daily dose, times 100 (under 100% means the label amount is below the study dose, which does not prove the ingredient fails).

Mind Lab Pro’s label allows 2 to 4 capsules a day; at 4 capsules its bacopa (300 mg) equals the trial dose and its lion’s mane (1,000 mg) is 95.2% of the trial dose, at twice the cost per day.

Seven ingredients together might offset part of those dose gaps if their effects added up; this is inferred, and no study has measured the combination. The populations also differ: two of the nine rows in the Effectiveness table enrolled people with a diagnosis (Alzheimer’s disease or an anxiety disorder), and one enrolled adolescents.

Mind Lab Pro Ingredients Nooceptin Does Not Contain

The same dose test applies to the six Mind Lab Pro ingredients that are not in Nooceptin (four table rows, because the three B vitamins share one):

Mind Lab Pro’s tyrosine form is at 7.1% of its study dose (14.2% at 4 capsules), its pine bark and B vitamins are at 50% or less, and its phosphatidylserine matches a study dose but the positive result was a subgroup finding.

Customer Reviews & Feedback

Nooceptin’s customer rating is 4.6 out of 5 from 845 reviews collected by the seller on its own website, and 4.1 out of 5 from 15 ratings on its Amazon listing, as of 10 Nov. 2026. No independent survey or trial of Nooceptin users’ satisfaction or side effects was found, so the two ratings above come from the seller’s site and one retailer listing only.

Nooceptin Dosage Instructions

Nooceptin’s label dose is one serving of 3 capsules a day (30 servings per 90-capsule bottle), as the seller’s FAQ also states.

• Conflicting instruction: another line on the Nooceptin home page says to take two capsules a day (a bottle would then last 45 days).
• Amount per capsule: the label gives no per-ingredient split; the 1,400 mg total averages 466.7 mg per capsule.
• Timing: the seller suggests taking the 3 capsules with a glass of water shortly after breakfast.

Nooceptin Side Effects & Safety

Nooceptin has no published safety data as a formula, so its side-effect rate and long-term safety are not established; the repeated-dose human trials of Nooceptin’s ingredients ran from 20 days to 49 weeks, and the single-dose studies covered one test session. The ingredients are mostly reported as tolerated, with mild effects; those below are reported for each ingredient alone, not measured for the formula (general patterns across supplements are covered in nootropic side effects):

• Ginkgo: headache, stomach upset and dizziness are commonly reported, and ginkgo may add to bleeding risk.
• Panax ginseng: trouble sleeping, headache and stomach upset are commonly reported.
• L-theanine: well tolerated in most reports; mild headache or drowsiness is occasionally reported.
• Citicoline: stomach upset, headache and trouble sleeping are occasionally reported.
• Bacopa: loose stools, stomach cramps, nausea and tiredness are commonly reported, and the 300 mg per day trial recorded increased stool frequency, cramps and nausea.
• Lion’s mane: generally well tolerated, though some people report stomach upset or a skin rash; the 1,050 mg per day mycelia trial recorded abdominal discomfort, nausea and skin rash.
• Rhodiola: restlessness, trouble sleeping and dry mouth are commonly reported, and the 340 mg per day pilot recorded dizziness and dry mouth.

Who Should Avoid Nooceptin and Interactions

Nooceptin has not been tested with medicines or in any specific group, so the points below are expected from what is known about each ingredient, and reports differ on several. Anyone with a medical condition or on prescription medication is advised to ask a doctor or pharmacist first.

• Children and teenagers: the formula has not been studied in anyone under 18, and Panax ginseng is commonly advised against for children, so it is not advised for them (inferred; reports differ).
• Pregnancy and breastfeeding: not studied for the formula; ginkgo and Panax ginseng are considered possibly unsafe in pregnancy (reports differ) and there are limited safety data for breastfeeding, so avoiding it unless a doctor agrees is the cautious default.
• Ginkgo: it may add to anticoagulant and antiplatelet effects (reports differ on how strongly), and stopping it about 2 weeks before surgery is commonly advised; it is also commonly advised against in epilepsy or with anticonvulsants, because it has been reported to lower the seizure threshold (reports differ).
• Panax ginseng, diabetes and warfarin: commonly reported to lower blood glucose, so an added effect is expected with diabetes medicines; reported to weaken warfarin (reports differ).
• Panax ginseng, MAO inhibitors, immune and hormone conditions: linked to headache, agitation or mania with MAO inhibitors such as phenelzine in case reports; reported to stimulate immune activity (autoimmune disease, immunosuppressants) and to have hormone-like effects (hormone-sensitive conditions), so ask a doctor first (reports differ).
• Stimulants and sleep: ginseng and rhodiola are reported to feel stimulating (inferred), so caffeine or prescription stimulants may add to restlessness or poor sleep even though Nooceptin lists no caffeine.
• Bipolar disorder and antidepressants: ginseng and rhodiola are commonly cautioned against in bipolar disorder (linked to mania), and rhodiola with antidepressants because it is reported to act on serotonin and dopamine systems (inferred; reports differ).
• Blood pressure: reports differ on whether ginseng raises or lowers blood pressure, L-theanine is reported to lower it slightly, and ginseng and rhodiola are reported to be stimulating, so checking first is commonly advised with hypertension or blood pressure medication.
• Thyroid medication: bacopa has been reported to affect thyroid hormone levels, mostly in animal data, so asking first is commonly advised.
• Cholinergic and anticholinergic drugs: bacopa and citicoline act on acetylcholine systems (inferred), so bacopa can oppose anticholinergic drugs and add mildly to cholinergic or anticholinesterase drugs.
• Slow heart rate, asthma or other lung conditions, stomach ulcers, urinary retention: bacopa is reported to act like acetylcholine, so ask a doctor first (inferred; reports differ).
• Sedatives, alcohol and levodopa: L-theanine is mildly relaxing, so it can add to sedatives, sleep medicines or alcohol (inferred), and citicoline has been reported to add to levodopa effects (minor; reports differ).
• Mushroom allergy, liver or kidney disease: people allergic to mushrooms are commonly advised to avoid lion’s mane; Nooceptin has not been studied in liver or kidney disease and the body clears plant extracts through those organs (inferred), so asking a doctor first is commonly advised.

Mind Lab Pro, the recommended alternative, carries the same cautions for the ingredients it shares with Nooceptin, plus these ingredient-specific cautions (expected from what is known about each ingredient; reports differ):

• Maritime pine bark extract: caution with blood thinners, before surgery, with diabetes medicines (it may lower blood sugar) and with immune-suppressing drugs or autoimmune disease; pregnancy and breastfeeding data are lacking (reports differ).
• N-acetyl-L-tyrosine: caution with thyroid medication and in hyperthyroidism, and with MAO inhibitors and levodopa.
• Phosphatidylserine: is expected to oppose anticholinergic drugs and add to cholinergic or anti-dementia (acetylcholinesterase-inhibitor) drugs (inferred); a possible added effect with blood thinners is also reported (reports differ).
• B vitamins: high-dose vitamin B6 is reported to cause nerve effects; Mind Lab Pro’s 2.5 mg is a low dose.
• Lion’s mane: avoid with a mushroom allergy.
• Rhodiola: caution in bipolar disorder and with antidepressants.
• Pregnancy, breastfeeding and under-18s: Mind Lab Pro has limited safety data in these groups and tyrosine passes into breast milk, so asking a doctor first is the cautious default.

Quality Assurance & Manufacturing Standards

Nooceptin’s label lists cellulose, silicon dioxide and hydroxypropyl methylcellulose as inactive ingredients. The seller states the product is made in an FDA-inspected facility, a seller claim rather than an approval. The seller’s home, product, terms and refund pages state no third-party laboratory testing and no certificate of analysis; the home page says only that the ingredients are “carefully researched and tested”, without naming a tester.

Price & Value for Money

Nooceptin costs $67.00 for a one-bottle (30-day) supply on nooceptin.com. The purchase options on nooceptin.com and their cost per day at 3 capsules are below; the 4-bottle deal is listed in the store catalogue but not on the home page.

• 1-month supply (90 capsules): $67.00, which is $2.23 per day
• 2-month supply (180 capsules): $120.00, which is $2.00 per day
• 3-month supply (270 capsules): $160.00, which is $1.78 per day
• 4-bottle deal (buy 3, get 1 free): $180.00, which is $1.50 per day
• 6-month supply (180 days): $414.00, which is $2.30 per day

The 6-month pack costs more per day than the one-month bottle, so it carries no saving at these prices. Twelve one-bottle supplies at $67.00 cost $804.00 before shipping and cover 360 days.

On 10 Nov. 2026 the “Retail” and “Savings” figures beside the home-page prices did not add up. A $69 retail price against the $67.00 sale price is a $2 saving, not the $10 shown; $138 against $120.00 is $18, not $29; and $207 against $160.00 is $47, not $98.

Mind Lab Pro lists at $69.00 per 30-day bottle ($2.30 per day at 2 capsules), and the first order of its 4-month subscription costs $187.68 ($1.56 per day), and renewals cost $207 every 4 months (about $1.73 per day). On each seller’s own website, Nooceptin’s 4-bottle deal at $1.50 per day is $0.06 per day below Mind Lab Pro’s $1.56 subscription first order, and Nooceptin’s one bottle at $2.23 is $0.07 per day below Mind Lab Pro’s $2.30. Other branded stacks are compared on the branded nootropic comparison page.

Where to Buy Nooceptin

Nooceptin is sold through the seller’s website, nooceptin.com, in packs of 1 to 6 months (see Price & Value for Money), and an Amazon listing exists (see Authorized Retailers vs. Official Website).

The seller states that orders are processed and shipped within 24 to 48 hours and that its tracked shipping should deliver within 3 to 5 business days in the USA; its shipping cost and delivery to Europe are not established.

Money-Back Guarantee

Nooceptin’s refund policy allows a return request within 30 days of receiving the item, and only for unused items in the original packaging, and it cannot accept returns on sale items. The seller shows its 2-month, 3-month and 4-bottle packs against higher “retail” prices and the policy does not define sale items, so returns on those packs may not be accepted.

Authorized Retailers vs. Official Website

The seller’s home page states that Nooceptin is not available on any third-party retailers, but an Amazon listing titled “NOOCEPTIN Nootropic Brain Supplement” (90 capsules, 30 servings) is shipped by Amazon and sold by SAPNutrition, a name that matches the SAP Nutrition Ltd contact in the seller’s terms of service; neither page states whether they are the same company. On 10 Nov. 2026 the listing price was $39.99, which is $1.33 per day at 3 capsules against $2.23 on nooceptin.com, and the listing says the item is non-returnable except when it arrives damaged or defective, so the 30-day refund terms apply to purchases from nooceptin.com; the listing did not show ingredient amounts, so its formula is not verified as identical to the label above.

Nooceptin Alternatives and Similar Supplements

Mind Lab Pro is the recommended alternative and is compared below; Vyvamind follows.

Nooceptin vs Mind Lab Pro

Mind Lab Pro is the recommended choice over Nooceptin because its finished formula has placebo-controlled trials and Nooceptin has none found; Mind Lab Pro’s trials are small, pseudo-randomised (participants were assigned in a way that was not fully random), company-funded (by Opti-Nutra, Performance Lab Group and ics-digital) and include one null result. The two share five ingredients at different amounts (citicoline, L-theanine, bacopa, lion’s mane and rhodiola; the Effectiveness table gives each); the Mind Lab Pro review covers its label and trials in full. Lion’s mane and citicoline are commonly paired in memory stacks (NGF activity and a choline source, inferred), but no study has tested the pair at these doses.

Mind Lab Pro’s three trials, each with unequal groups:

• 30 days, 2 capsules a day, 61 Mind Lab Pro users and 44 on placebo: the groups differed in simple reaction time, choice reaction time and anticipation timing, although the placebo group was faster for simple reaction time at baseline; funded by a grant from ics-digital. ⁽¹⁷⁾
• 30 days, 2 capsules a day (60 capsules), 36 users and 13 on placebo (4 control participants were removed after catching Covid-19): a difference in delayed recall (p = 0.034) and a borderline one in immediate recall (p = 0.05 in the full text, about 0.053 when recomputed from chi2 = 3.747; the abstract’s 0.005 does not match the full text); funded by Opti-Nutra. ⁽¹⁸⁾
• 60 days, 2 capsules a day, 17 users and 15 on placebo: no improvement in choice accuracy or reaction time, only changes in EEG measures (EEG records the brain’s electrical activity through scalp electrodes) of how brain regions work together; funded by Performance Lab Group. ⁽¹⁹⁾

Of the three funders, Opti-Nutra (the maker, per the Mind Lab Pro blog) funded the Abbott-Imboden trial and Performance Lab Group (the parent company, per the product page) funded the O’Reilly trial; ics-digital, which funded Utley, is not linked to the maker in any source read. Mind Lab Pro’s marketing claim of a “47% Reduction in information processing time” matches a 46.7% smaller anticipation-timing error in the Mind Lab Pro group (0.15 s to 0.08 s), not a change in processing time.

Nooceptin still fits a buyer who specifically wants Panax ginseng and ginkgo in one caffeine-free capsule, or more rhodiola (150 mg) and bacosides (60 mg) per serving than Mind Lab Pro supplies, and who accepts ingredient-level evidence. It does not fit a buyer who wants a formula tested as a whole or a 60-day first-order refund window. Because several of Mind Lab Pro’s own ingredient doses fall short, the recommendation rests on its finished-formula trials, not on ingredient doses.

Nooceptin vs Vyvamind

Vyvamind differs from Nooceptin mainly in caffeine. A 2-capsule Vyvamind serving lists 75 mg of caffeine with 150 mg of L-theanine, 300 mg of L-tyrosine, 200 mg of citicoline sodium, plus vitamins B6 and B12, while Nooceptin and Mind Lab Pro list no caffeine.

As of 10 Nov. 2026, Vyvamind’s one-time Amazon price is $56.99 per 60-capsule bottle, which is $1.90 per day at 2 capsules, against $1.33 per day for Nooceptin’s Amazon listing, so Nooceptin is cheaper per day on Amazon, if the Amazon formula matches the label (the Amazon listing did not show ingredient amounts, so that is not verified). Vyvamind’s own site sends buyers to that Amazon store at the same $56.99 and shows no separate own-site price, while Nooceptin’s own site is $2.23 per day and Mind Lab Pro’s own site is $2.30. The two share citicoline (200 mg each) and L-theanine (150 mg against 200 mg).

FAQs

1. Lai, Puei-Lene, et al. “Neurotrophic properties of the Lion’s mane medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia.” International journal of medicinal mushrooms vol. 15,6 539-54. 2013, doi:10.1615/intjmedmushr.v15.i6.30↩
2. Li, I-Chen, et al. “Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study.” Frontiers in aging neuroscience vol. 12 155. 3 Jun. 2020, doi:10.3389/fnagi.2020.00155↩
3. Silveri, M M, et al. “Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy.” NMR in biomedicine vol. 21,10 1066-75. Nov. 2008, doi:10.1002/nbm.1281↩
4. McGlade, Erin, et al. “The Effect of Citicoline Supplementation on Motor Speed and Attention in Adolescent Males.” Journal of attention disorders vol. 23,2 121-134. 15 Jul. 2015, doi:10.1177/1087054715593633↩
5. Baba, Yoshitake, et al. “Effects of l-Theanine on Cognitive Function in Middle-Aged and Older Subjects: A Randomized Placebo-Controlled Study.” Journal of medicinal food vol. 24,4 333-341. 22 Mar. 2021, doi:10.1089/jmf.2020.4803↩
6. Reay, Jonathon L, et al. “Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity.” Journal of psychopharmacology (Oxford, England) vol. 19,4 357-65. Jul. 2005, doi:10.1177/0269881105053286↩
7. Namgung, Eun, et al. “Effects of Korean red ginseng on human gray matter volume and cognitive function: A voxel-based morphometry study.” Human psychopharmacology vol. 36,2 e2767. 20 Nov. 2020, doi:10.1002/hup.2767↩
8. Spasov, A A, et al. “A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen.” Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 7,2 85-9. Apr. 2000, doi:10.1016/S0944-7113(00)80078-1↩
9. Bystritsky, Alexander, et al. “A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD).” Journal of alternative and complementary medicine (New York, N.Y.) vol. 14,2 175-80. Mar. 2008, doi:10.1089/acm.2007.7117↩
10. Morgan, Annette, and John Stevens. “Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial.” Journal of alternative and complementary medicine (New York, N.Y.) vol. 16,7 753-9. Jul. 2010, doi:10.1089/acm.2009.0342↩
11. Vollala, Venkata Ramana, et al. “Enhancement of basolateral amygdaloid neuronal dendritic arborization following Bacopa monniera extract treatment in adult rats.” Clinics (Sao Paulo, Brazil) vol. 66,4 663-71. 2011, doi:10.1590/s1807-59322011000400023↩
12. Solomon, Paul R, et al. “Ginkgo for memory enhancement: a randomized controlled trial.” JAMA vol. 288,7 835-40. 21 Aug. 2002, doi:10.1001/jama.288.7.835↩
13. Colzato, Lorenza S, et al. “Working memory reloaded: tyrosine repletes updating in the N-back task.” Frontiers in behavioral neuroscience vol. 7 200. 16 Dec. 2013, doi:10.3389/fnbeh.2013.00200↩
14. Ryan, J, et al. “An examination of the effects of the antioxidant Pycnogenol on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population.” Journal of psychopharmacology (Oxford, England) vol. 22,5 553-62. Jul. 2008, doi:10.1177/0269881108091584↩
15. Smith, A David, et al. “Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.” PloS one vol. 5,9 e12244. 8 Sep. 2010, doi:10.1371/journal.pone.0012244↩
16. Kato-Kataoka, Akito, et al. “Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints.” Journal of clinical biochemistry and nutrition vol. 47,3 246-55. 29 Sep. 2010, doi:10.3164/jcbn.10-62↩
17. Utley, Andrea, et al. “The Efficacy of A Nootropic Supplement on Information Processing in Adults: A Double Blind, Placebo Controlled Study.” Biomedical Journal of Scientific & Technical Research vol. 49,1 BJSTR.MS.ID.007746. 3 Mar. 2023, doi:10.26717/BJSTR.2023.49.007746↩
18. Abbott-Imboden, Carlie, et al. “Efficacy of the nootropic supplement Mind Lab Pro on memory in adults: Double blind, placebo-controlled study.” Human psychopharmacology vol. 38,4 e2872. 17 May 2023, doi:10.1002/hup.2872↩
19. O’Reilly, David, et al. “Effect of a Plant-Based Nootropic Supplement on Perceptual Decision-Making and Brain Network Interdependencies: A Randomised, Double-Blinded, and Placebo-Controlled Study.” Brain sciences vol. 15,3 226. 21 Feb. 2025, doi:10.3390/brainsci15030226↩